Welcome to LookChem.com Sign In|Join Free
  • or
Cyclohexanone, 4-(3-hydroxypropyl)-, also known as 4-(3-hydroxypropyl)cyclohexanone or 4-(3-hydroxypropyl)-1-cyclohexanone, is an organic compound with the chemical formula C9H16O2. It is a colorless to pale yellow liquid with a molecular weight of 156.22 g/mol. Cyclohexanone, 4-(3-hydroxypropyl)- is characterized by a cyclohexanone ring with a 3-hydroxypropyl group attached at the 4-position. It is used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals. Cyclohexanone, 4-(3-hydroxypropyl)-, is known for its versatile reactivity and can be further functionalized to produce a range of derivatives, making it a valuable building block in organic chemistry.

5597-54-6

Post Buying Request

5597-54-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5597-54-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5597-54-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,9 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 5597-54:
(6*5)+(5*5)+(4*9)+(3*7)+(2*5)+(1*4)=126
126 % 10 = 6
So 5597-54-6 is a valid CAS Registry Number.

5597-54-6Downstream Products

5597-54-6Relevant academic research and scientific papers

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN

-

, (2022/05/02)

Bifunctional compounds, which find utility as modulators of androgen receptor (AR), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds AR, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5597-54-6